Where does John Josey work?

John Josey is Partner at The Column Group and Board director at Day One Biopharmaceuticals and Board director at Circle Pharma.

What check size does John Josey write?

John Josey typically writes checks of $100K – $5M.

What boards does John Josey sit on?

John Josey holds tracked board seats at Circle Pharma, Day One Biopharmaceuticals.

Where did John Josey go to school?

John Josey studied at Caltech (Postdoctoral Fellow); The University of Texas at Austin (Ph.D., Organic Chemistry); University of Colorado (MBA, Business Administration).

John Josey

Investor

Partner at The Column Group · Board director at Day One Biopharmaceuticals · Board director at Circle Pharma

Dallas, Texas

Writes $100K – $5M checks · typically $1.5M

Find your path to John

221 people in our graph can introduce you to John.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Derek DiRocco to introduce you to John

You →Derek · together at Peloton Therapeutics (2019) →John

Ask Jamie Chen to introduce you to John

You →Jamie · 7 people · together at Arraybiopharma →John

Ask Sam Okafor to introduce you to John

You →Sam · 4 people · together at The Column Group →John

Your email: the people you already email who know John
2nd- and 3rd-degree connections: people you know who worked, studied or invested with John
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Joined The Column Group as a Venture Partner in 2020. Former President and CEO of Peloton Therapeutics until its 2019 acquisition by Merck; earlier a founding management team member at Array BioPharma. Holds a PhD in organic chemistry.

Board director at Day One Biopharmaceuticals

Intro paths

→

In turn, John can intro founders to Day One Biopharmaceuticals's investors below.

Day One Biopharmaceuticals's investors · 7

Access BiotechnologyNew York · since 2021 Access IndustriesNew York · since 2020 Atlas VentureCambridge · $500K – $1M checks · since 2021 Canaan PartnersStamford · $500K – $20M checks · since 2021 RA CapitalBoston · since 2021 The Column GroupSan Francisco · $30M checks · since 2021 Viking GlobalStamford

Board director at Circle Pharma

Intro paths

→

In turn, John can intro founders to Circle Pharma's investors below.

Circle Pharma's investors · 10

Berkeley CatalystBerkeley Hemisphere Ventures LLCMckinney Jude GomilaLynnwood Lifeforce CapitalChevy Chase · $500K – $5M checks Mission Bay CapitalSan Francisco Mission BiocapitalSan Francisco · $500K checks · since 2017 Nextech InvestZurich · $648K – $3.2M checks · since 2020 Pandect BioventuresWoodside · since 2024 The Column GroupSan Francisco · $30M checks · since 2021 WI Harper GroupSan Francisco · $5M – $15M checks

Co-founders at Circle Pharma

Matthew P. JacobsonCo-founder

Scott R. LokeyDirector

Experience

The Column GroupPartnercurrent2026 — present
The Column GroupVenture Partner2020 — 2026
Peloton TherapeuticsPresident and Chief Executive Officer2013 — 2019Dallas, Texas
Peloton TherapeuticsPresident and Chief Scientific Officer2011 — 2013Dallas, TX
Array BioPharma Inc.Vice President, Discovery Chemistry1998 — 2011
AmgenScientist1995 — 1998
Glaxo Inc.Research Scientist1991 — 1995Research Triangle Park, NC

Deals · 2

Circle PharmaBoard seat

via The Column Group · filed Jan 2025 · $117.4M raise

Day One BiopharmaceuticalsBoard seat

via The Column Group · filed Feb 2021 · $130M raise

Attribution from SEC filings, press coverage, and firm rosters.

Leave your own feedback

Colleagues at The Column Group

Aadit Shah

Principal at The Column Group

Arnav Mehta, MD, PhD

Venture Partner at The Column Group

Betty Liu

Swanson Fellow at The Column Group

Brooke Sorenson

Administrative Coordinator at The Column Group

Carla Daniel

Partner at The Column Group

Charles Sawyers

Science Partner at The Column Group

Charles Zuker

Science Partner at The Column Group

Craig Parker

Venture Partner at The Column Group

Frequently asked questions

Who is John Josey?: Joined The Column Group as a Venture Partner in 2020. Former President and CEO of Peloton Therapeutics until its 2019 acquisition by Merck; earlier a founding management team member at Array BioPharma. Holds a PhD in organic chemistry.
Where does John Josey work?: John Josey is Partner at The Column Group and Board director at Day One Biopharmaceuticals and Board director at Circle Pharma.
What check size does John Josey write?: John Josey typically writes checks of $100K – $5M.
What boards does John Josey sit on?: John Josey holds tracked board seats at Circle Pharma, Day One Biopharmaceuticals.
Where did John Josey go to school?: John Josey studied at Caltech (Postdoctoral Fellow); The University of Texas at Austin (Ph.D., Organic Chemistry); University of Colorado (MBA, Business Administration).